Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma

<div>Diagnostic ability of exosomal telomerase RNA component (TERC) and nuclear matrix protein- (NMP-) 22 for bladder urothelial carcinoma (BLCA). (a–c) Receiver operating characteristic curve analysis of exosomal TERC and NMP-22 (ELISA) and the combination of these indicators revealed area under the curve values of 0.836, 0.696, and 0.861.</div>

Journal of Immunology Research

fig4

Figure 4

Figure 4: Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma 